JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meirelles, G. S.P.
Right arrow Articles by Schöder, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meirelles, G. S.P.
Right arrow Articles by Schöder, H.

Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions

Gustavo S.P. Meirelles1, Yusuf Emre Erdi2, Sadek A. Nehmeh2, Olivia D. Squire1, Steven M. Larson1, John L. Humm2 and Heiko Schöder1

1 Department of Radiology, Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York; and 2 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York


Figure 1
View larger version (78K):
[in this window]
[in a new window]

 
FIGURE 1.  (A) Patient with lung cancer with 2 additional nodules on left lung on BH CT (arrows). (B) Clinical CT does not show lesions.

 

Figure 2
View larger version (79K):
[in this window]
[in a new window]

 
FIGURE 2.  Patient with widespread metastatic colonic adenocarcinoma to lungs, with consolidations and GGOs. Although clinical CT demonstrates findings (A and B), BH examination (C and D) has much better quality to define lesions' borders and characteristics.

 

Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
FIGURE 3.  (A) BH PET/CT of patient with adenocarcinoma of left lung, with 18F-FDG PET uptake in pulmonary mass (arrows) and SUVmax of 23.3 g/mL, which was 21.2 g/mL on clinical PET/CT. (B and C) Use of BH CT allows detection of carcinomatous lymphangitis adjacent to tumor, characterized by septal thickening (B, arrows), GGOs, and small nodules (C, arrows). (D) It is very hard to depict and characterize the same findings on clinical non-BH CT.

 

Figure 4
View larger version (33K):
[in this window]
[in a new window]

 
FIGURE 4.  Lung cancer metastasis to subcarinal (level 7) lymph node. Although clinical PET/CT detects lesion (A, arrow), SUVmax of 7.8 mg/dL is significantly lower than SUVmax of 12.0 mg/dL measured on same lesion with BH PET/CT (B, arrow). (C) Coronal view of clinical PET/CT reveals breathing artifacts near diaphragm (dashed arrows) in addition to subcarinal node (solid arrow).

 

Figure 5
View larger version (27K):
[in this window]
[in a new window]

 
FIGURE 5.  (A and B) Clinical PET/CT showed focus of 18F-FDG uptake projecting on upper lobe of right lung on transaxial (A) and coronal (B) images (arrows). (C and D) BH PET/CT clearly localized focus of 18F-FDG uptake to right third rib on transaxial (C) and coronal (D) images (arrows). This is clear example of mislocalization on standard PET/CT without BH technique.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.